G-NiiB Oral Microbiome Immunity Formula SIM01 Alleviates Post-COVID-19 Conditions
Clinical Study Published in the Prestigious International Medical Journal The Lancet Infectious Diseases HONG KONG SAR – Media OutReach Newswire – 8 December 2023 – Hong Kong’s leading biomedical and microbiome technology company, G-NiiB GenieBiome, is pleased to announce that a ground-breaking large-scale randomised, double-blind, placebo-controlled clinical trial (“the Trial”) conducted on the efficacy of SIM01, an oral microbiome immunity formula developed by a top-notch medical school […]

